Alexion Pharmaceuticals

Alexion Highlights Brighter Futures in 2019 CSR Report


March 30, 2020 - Alexion Pharmaceuticals (NASDAQ: ALXN), a global biopharmaceutical company focused on serving patients and families affected by rare diseases through the discovery, development and commercialization of life-changing medicines, releases its inaugural corporate social responsibility (CSR) report, Brighter Futures.

Teamwork Makes the Dream Work


In your career, there is a high likelihood that you will be the member of a team. Sometimes team members work very closely with one another while other times teams are more dependent on individual contributors due to the technical nature of tasks or expertise. We sought to find advice from an expert as to how best to lead a team.

Alexion Interns Get Career Advice From Senior Leaders


Each summer, Alexion hosts interns at its headquarters in Boston and its R&D Center of Excellence in New Haven, Connecticut. One of the highlights of the program is Intern Day, a full-day workshop dedicated to advancing the interns’ knowledge of Alexion, providing career coaching and sharing advice from senior leaders. This year, nearly 30 interns participated in the workshop and enjoyed having the opportunity to: 

1. Take a tour of the labs in New Haven, where new therapies are discovered and developed; 

Alexion Intern Returns as Post-Doc Fellow


The depth of Alexion’s commitment to serving the rare disease community is what kept drawing Global Medical Affairs Fellow, Adam Quicquaro, PharmD, back to the company. After completing his internship in Global Medical Information and Medical Review at Alexion, Adam returned to Massachusetts College of Pharmacy and Health Science University to complete his Doctor of Pharmacy degree.

Alexion Partners With PluSport for Second Year


July in Zurich began with five Alexion employees traveling to Magglingen for the 58th PluSport Day, a recreational sports event that brings together 1,500 athletes with disabilities. This is Alexion’s second year working with PluSport, Switzerland’s umbrella organization for handicapped sports. Alexion employees spent the day refereeing and facilitating a variety of activities including a crowd favorite, the basketball toss. 

Alexion Partners With White & Case to Host a 1L Diversity Fellow at Its Boston Headquarters


This summer, for the first time, Alexion partnered with law firm White & Case to host a Diversity Fellow at its Boston Headquarters. White & Case’s 1L Diversity Fellowship program provides qualified first-year law students with experience working with clients, specifically those seeking to create an environment where the diversity of thought and background are not only encouraged, but preferred.

Listening and Learning From the Rare Disease Patient


In the world of rare diseases, where so many conditions remain undiagnosed and untreated, we take seriously the opportunity to really listen to and learn from patients and caregivers and their healthcare providers. At Alexion, innovation includes really focusing our collective efforts to strive toward understanding patients’ needs, including meaningful therapies and beyond. We are focused on innovating in all we do to improve the day-to-day experience of people living with a rare disease.


Subscribe to Alexion Pharmaceuticals